↓ Skip to main content

Cochrane Database of Systematic Reviews

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

Overview of attention for article published in this source, April 2013
Altmetric Badge

Mentioned by

blogs
1 blog
twitter
9 X users
facebook
1 Facebook page

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
115 Mendeley
citeulike
1 CiteULike
Title
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus
Published by
John Wiley & Sons, Ltd, April 2013
DOI 10.1002/14651858.cd009008.pub2
Pubmed ID
Authors

Hemmingsen, Bianca, Schroll, Jeppe B, Lund, Søren S, Wetterslev, Jørn, Gluud, Christian, Vaag, Allan, Sonne, David Peick, Lundstrøm, Lars H, Almdal, Thomas P

Abstract

Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether sulphonylureas show better, equal or worse therapeutic effects in comparison with other antidiabetic interventions for patients with T2DM remains controversial.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 115 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Denmark 1 <1%
Ireland 1 <1%
Brazil 1 <1%
Unknown 111 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 16%
Student > Master 15 13%
Student > Postgraduate 13 11%
Student > Ph. D. Student 10 9%
Student > Bachelor 9 8%
Other 25 22%
Unknown 25 22%
Readers by discipline Count As %
Medicine and Dentistry 61 53%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Nursing and Health Professions 4 3%
Economics, Econometrics and Finance 3 3%
Social Sciences 3 3%
Other 7 6%
Unknown 31 27%